Content type

Quick View: Johnson & Johnson's Pricing Agreement Will Reshape Affordability Of Tuberculosis Treatment in South Africa

Pharmaceuticals / South Africa / Tue 31 Oct, 2023

The Latest: On October 24 2023, Johnson & Johnson (J&J) and the government of South Africa reached an agreement to reduce the price of Sirturo (bedaquiline), a drug-resistant tuberculosis (TB) medication, by over 40%. This is significant for the market, given that the WHO estimated that there were over 50,000 deaths attributed to TB in South

Read More

Tepid Growth For South Sudan In 2023-2024, With Downside Risks

Country Risk / Sudan / Wed 18 Oct, 2023

Key View

  • We forecast that real GDP growth in South Sudan will accelerate slightly from 2.0% in 2023 to 2.6% in 2024.
  • Rising domestic crude output and global oil prices will increase room for government spending ahead of elections currently due to be held by December 2024.
  • However, widespread inter-communal violence, rising inflation and
Read More

SARB To Maintain Hold In Q423, Cut In 2024

Country Risk / South Africa / Thu 12 Oct, 2023

Key View

  • We expect that the SARB will maintain its policy rate at 8.25% over the remainder of 2023, following its decision to hold on September 21.
  • In 2024, we forecast that the SARB will cut the policy rate by 100bps to 7.25% amid a general shift to global monetary easing and a still-weak domestic economic outlook.
  • Risks remain tilted
Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.